Codon Devices, Inc., a biotechnology company, focuses on commercial applications of synthetic biology. Its products include gene synthesis, constructed variant libraries, constructed operons and operon variant libraries, and biological parts discovery and optimization. The company develops and delivers products and design services in various application areas, including engineered gene libraries, engineered cells that produce pharmaceuticals, vaccines, agricultural products, and biorefineries for the production of industrial chemicals and energy. Its synthesis and design technologies serve industrial, pharmaceutical, and academic customers. The company was founded in 2004 as Synbio Corporation and changed its name to Codon Devices, Inc. in 2005. Codon Devices, Inc. is headquartered in Cambridge, Massachusetts.